CHELSEA FLOWE: Open Payments
NPI 1871682815 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,253 in 99 payments from 21 companies in 2025. Trend: 2023 $2,055 · 2024 $1,849 · 2025 $2,253
Food & beverage: $2,253
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $380 |
| Novo Nordisk Inc | 13 | $324 |
| Lilly USA, LLC | 13 | $276 |
| ABBVIE INC. | 18 | $273 |
| Tandem Diabetes Care, Inc. | 7 | $203 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $110 |
| Radius Health, Inc. | 4 | $99 |
| Insulet Corporation | 1 | $86 |
| Abbott Laboratories | 4 | $79 |
Products named: SYNTHROID, JARDIANCE, Ozempic, EVENITY, t:slim X2 Insulin Pump with Control-IQ, VOQUEZNA, MOUNJARO, OMNIPOD.
Industry payments across CA — which companies pay providers there.
